1. Home
  2. ASTI vs ATOS Comparison

ASTI vs ATOS Comparison

Compare ASTI & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascent Solar Technologies Inc.

ASTI

Ascent Solar Technologies Inc.

N/A

Current Price

$1.54

Market Cap

30.0M

Sector

Technology

ML Signal

N/A

Logo Atossa Therapeutics Inc.

ATOS

Atossa Therapeutics Inc.

N/A

Current Price

$2.07

Market Cap

25.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ASTI
ATOS
Founded
2005
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.0M
25.9M
IPO Year
2014
2010

Fundamental Metrics

Financial Performance
Metric
ASTI
ATOS
Price
$1.54
$2.07
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $19.00
AVG Volume (30 Days)
★ 231.0K
73.9K
Earning Date
11-06-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 70.23
N/A
EPS
★ N/A
N/A
Revenue
★ $10,398,149.00
$1,758.00
Revenue This Year
$987.62
N/A
Revenue Next Year
$2,579.52
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 163.25
N/A
52 Week Low
$1.40
$0.53
52 Week High
$9.87
$7.56

Technical Indicators

Market Signals
Indicator
ASTI
ATOS
Relative Strength Index (RSI) 38.06 39.61
Support Level N/A $1.76
Resistance Level $1.84 $2.60
Average True Range (ATR) 0.17 0.18
MACD 0.03 -0.04
Stochastic Oscillator 29.79 7.47

Price Performance

Historical Comparison
ASTI
ATOS

About ASTI Ascent Solar Technologies Inc.

Ascent Solar Technologies Inc is a solar technology company that manufactures and sells photovoltaic (PV) solar modules that are flexible, durable, and possess attractive power to weight and power to area performance. Its technology provides renewable power solutions to high-value production and specialty solar markets where traditional rigid solar panels are not suitable, including space power beaming, aerospace, satellites, near earth orbiting vehicles, fixed wing unmanned aerial vehicles (UAV), aquatic, terrestrial, and other weight-sensitive markets with transformational high quality, value added product applications. It operates in single PV segment that sells PV products and engineering services and currently, is selling it in North America.

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.

Share on Social Networks: